There was a napkin. That's where it started.
Melissa Burdick had spent nearly a decade inside Amazon, back when advertising there was barely a business — more of a hunch, really, about where all that shopping data might lead. She helped build it into something real. And then she sat down and sketched, on a napkin, the idea for a company that would help other brands make sense of the machine she'd spent years understanding from the inside.
Pacvue. That was the name for the thing on the napkin.
She had a plan. A launch date. Momentum. The kind of clean runway an entrepreneur dreams about.
Then, days before she meant to launch, the phone rang. Aggressive breast cancer.
Most stories tell you what a person did when the news landed. This one is more interesting than that, because Melissa will tell you the diagnosis didn't stop the company — it changed the woman starting it.
She talks about it the way you'd talk to a friend who'd been through the same fire. Cancer, she says, rewired her relationship to risk. When you have stared down the worst thing, the ordinary terrors of building a company — the payroll, the doubt, the investor who passes, the market that shifts — start to look like exactly what they are. Manageable. Survivable. Small, next to the real thing.
"When you've faced your own mortality, business risk stops feeling like risk."
That's the sentence that reorganizes everything. Because most of us hold ourselves back not from lack of talent but from fear of the fall. Melissa had already fallen and climbed back. So she built.
Pacvue became the software that brands and agencies use to run their retail advertising — the bidding, the budgets, the endless optimization across marketplaces most people never think about while they're clicking "buy." The unglamorous plumbing of modern commerce. She built it fast and she built it right, and in under four years the company was acquired. Today the platform powers more than twelve billion dollars in ad spend.
Twelve billion. From a napkin and a diagnosis that arrived on the same short stretch of calendar.
I love this story not because it's triumphant — though it is — but because of what it refuses to do. It refuses to make cancer the villain or the excuse. Melissa doesn't cast herself as a victim who overcame, and she doesn't wrap the illness in a bow and call it a gift. She's more honest than that. The illness was terrible. It was also clarifying. Both things are true, and she holds them both without flinching.
That's the part I want women to carry with them. Not "survive cancer and you'll build a unicorn." No. The lesson underneath it: the fear you're negotiating with right now is smaller than you think. The launch you keep postponing. The idea on your own napkin.
Melissa didn't wait until she felt safe. She was, by any measure, at her least safe. She went anyway.
And the thing about a woman who's already met the worst and kept going — she doesn't run out of runway. She keeps finding more.
